Skip to main content

Advertisement

Log in

Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

A liquid chromatography/time-of-flight mass spectrometry (LC-TOF-MS) method for targeted toxicological screening in human postmortem blood samples from forensic autopsy cases has been developed, validated and compared with a previously used method using gas chromatography with nitrogen–phosphorus detection (GC-NPD). Separation was achieved within 12 min by high-resolution gradient chromatography. Ions were generated in positive and negative electrospray ionization mode and were detected in 2-GHz single mass spectrometry mode, m/z range 50–1,000. Before injection, 0.25 g blood was prepared by protein precipitation with 500 μL of a mixture of acetonitrile and ethanol containing deuterated internal standards. An in-house database comprising 240 drugs and metabolites was built by analysing solutions from certified standards or other documented reference material available. Identification was based on scoring of retention time, accurate mass measurement and isotopic pattern. Validation was performed on spiked blood samples and authentic postmortem blood samples. The thresholds defined as minimum required performance levels were for most compounds in the range from 0.01 to 0.10 μg/g. Typically, a mass error of less than 2 ppm and a precision of area measurements of less than 5 % coefficient of variation were achieved. Positive identification was confirmed at concentrations up to 500 μg/g. Most compounds were determined in positive ionization mode, but for a limited number of compounds (fewer than 4 %) negative ionization was needed and a few early-eluted compounds could not be identified owing to substantial influence of interferences from the matrix and were thus not included in the screening. A robust and valid toxicological screening by LC-TOF-MS for postmortem blood samples, covering 50 % more compounds, and with higher precision and sensitivity than the previously used screening by GC-NPD was achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Maurer HH (2004) Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. Clin Chem Lab Med 42:1310–1324

    Article  CAS  Google Scholar 

  2. Drummer OH (2007) Requirements for bioanalytical procedures in postmortem toxicology. Anal Bioanal Chem 388:1495–1503

    Article  CAS  Google Scholar 

  3. Peters FT (2011) Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem 44:54–65

    Article  CAS  Google Scholar 

  4. Skopp G (2010) Postmortem toxicology. Forensic Sci Med Pathol 6:314–325

    Article  CAS  Google Scholar 

  5. Maurer HH (2010) Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther Drug Monit 32:324–327

    Article  CAS  Google Scholar 

  6. Ojanperä I, Kolmonen M, Pelander A (2012) Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal Bioanal Chem 403:1203–1220

    Article  Google Scholar 

  7. Ojanperä I, Pelander A, Laks S, Gergov M, Vuori E, Witt M (2005) Application of accurate mass measurement to urine drug screening. J Anal Toxicol 29:34–40

    Google Scholar 

  8. Ojanperä S, Pelander A, Pelzing M, Krebs I, Vuori E, Ojanperä I (2006) Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 20:1161–1167

    Article  Google Scholar 

  9. Lee HK, Ho CS, Iu YPH, Lai PSJ, Shek CC, Lo Y-C, Bendstrup Klinke H, Wood M (2009) Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry. Anal Chim Acta 649:80–90

    Article  CAS  Google Scholar 

  10. Tyrkkö E, Pelander A, Ojanperä I (2010) Differentiation of structural isomers in a target drug database by LC/Q-TOFMS using fragmentation prediction. Drug Test Anal 2:259–270

    Article  Google Scholar 

  11. Bijlsma L, Sancho JV, Hernández F, Niessen WM (2011) Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra. J Mass Spectrom 46:865–875

    Article  CAS  Google Scholar 

  12. Broecker S, Herre S, Wüst B, Zweigenbaum J, Pragst F (2011) Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal Bioanal Chem 400:101–117

    Article  CAS  Google Scholar 

  13. De Castro A, Gergov M, Östman P, Ojanperä I, Pelander A (2012) Combined drug screening and confirmation by liquid chromatography time-of-flight mass spectrometry with reverse database search. Anal Bioanal Chem 403:1265–1278

    Article  Google Scholar 

  14. Kolmonen M, Leinonen A, Kuuranne T, Pelander A, Ojanperä I (2009) Generic sample preparation and dual polarity liquid chromatography-time-of-flight mass spectrometry for high-throughput screening in doping analysis. Drug Test Anal 1:250–266

    Article  CAS  Google Scholar 

  15. Peters RJB, Oosterink JE, Stolker AA, Georgakopoulos C, Nielen MW (2010) Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. Anal Bioanal Chem 396:2583–2598

    Article  CAS  Google Scholar 

  16. Dalsgaard PW, Rasmussen BS, Müller IB, Linnet K (2011) Toxicological screening of basic drugs in whole blood using UPLC-TOF-MS. Drug Test Anal 4:313–319

    Article  Google Scholar 

  17. Marin SJ, Huges JM, Lawlor BG, Chantry JC, McMillin GA (2012) Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS. J Anal Toxicol 36:477–486

    Article  CAS  Google Scholar 

  18. Pelander A, Ristimaa J, Rasanen I, Vuori E, Ojanperä I (2008) Screening for basic drugs in hair of drug addicts by liquid chromatography/time-of-flight mass spectrometry. Ther Drug Monit 30:717–724

    Article  CAS  Google Scholar 

  19. Nielsen MK, Johansen SS, Dalsgaard PW, Linnet K (2010) Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS. Forensic Sci Int 196:85–92

    Article  CAS  Google Scholar 

  20. Domínguez-Romero JC, García-Reyes JF, Molina-Díaz A (2011) Screening and quantitation of multiclass drugs of abuse and pharmaceuticals in hair by fast liquid chromatography electrospray time-of-flight mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 879:2034–2042

    Article  Google Scholar 

  21. Broecker S, Herre S (2011) Pragst F (2011) General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). Forensic Sci Int 218:68–81

    Article  Google Scholar 

  22. Pelander A, Ristimaa J, Ojanperä I (2010) Vitreous humor as an alternative matrix for comprehensive drug screening in postmortem toxicology by liquid chromatography-time-of-flight mass spectrometry. J Anal Toxicol 34:312–318

    CAS  Google Scholar 

  23. Ristimaa J, Gergov M, Pelander A, Halmesmäki E, Ojanperä I (2010) Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry. Anal Bioanal Chem 398:925–935

    Article  CAS  Google Scholar 

  24. Careri M, Mangia A (2006) Validation and qualification: the fitness for purpose of mass spectrometry-based analytical methods and analytical systems. Anal Bioanal Chem 386:38–45

    Article  CAS  Google Scholar 

  25. Peters F, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216–224

    Article  CAS  Google Scholar 

  26. Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in post-mortem femoral blood. J For Sci 42:79–87

    Google Scholar 

  27. United Nations Office on Drugs and Crime (2011) Guidelines for the forensic analysis of drugs facilitating sexual assault and other criminal acts (2011) United Nations Office on Drugs and Crime, Vienna. http://www.unodc.org/documents/scientific/forensic_analys_of_drugs_facilitating_sexual_assault_and_other_criminal_acts.pdf. Accessed 21 Dec 2012

  28. Polson C, Sarkar P, Incledon B, Raguvaran V, Grant R (2003) Optimimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography tandem mass spectrometry. J Chromatogr B 785:263–275

    Article  CAS  Google Scholar 

  29. Chambers E, Wagrowski-Diehl DM, Lu Z, Masseo JR (2007) Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B 852:22–34

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Josefsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roman, M., Ström, L., Tell, H. et al. Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening. Anal Bioanal Chem 405, 4107–4125 (2013). https://doi.org/10.1007/s00216-013-6798-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-013-6798-0

Keywords

Navigation